2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Type2diabetes: new trials by email Literature Review of Type2diabetes trials Research Report on Type2diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh Omarigliptin, Sulphonylureas, Metformin - Type2diabetes | Phase 4 | Unknown | Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders | 938 | 2024-09-01 | 2024-07-16 |
| Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD Empagliflozin 10 MG, Pioglitazone 15mg, Metformin - Non-Alcoholic Fatty Liver Disease, Type2diabetes | Phase 4 | Unknown | Jinnah Postgraduate Medical Centre | 240 | 2023-10-01 | 2023-07-12 |
Diabetes Mellitus, Type 2 (1) · Non-alcoholic Fatty Liver Disease (1)
Diabetes Mellitus (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Fatty Liver (1) · Glucose Metabolism Disorders (1) · Liver Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Metformin (2) · 2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4-c)pyrazol-5(4H)-yl)tetrahydro-2H-pyran-3-amine (1) · Glucagon-Like Peptide 1 (1) · Glycoside Hydrolase Inhibitors (1) · Pioglitazone (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · Sulfonylurea Compounds (1) · Thiazolidinediones (1) · empagliflozin (1)
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (1) · Jinnah Postgraduate Medical Centre (1)
Bangladesh (1) · Pakistan (1)
Faria Afsana, MD (1)